Title |
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
|
---|---|
Published by |
John Wiley & Sons, Ltd, October 2009
|
DOI | 10.1002/14651858.cd007435.pub2 |
Pubmed ID | |
Authors |
Ho, Meghan J, Bellusci, Anthony, Wright, James M |
Abstract |
Studies have shown that coenzyme Q10 deficiency is associated with cardiovascular disease. Hypertension is a commonly measured surrogate marker for non-fatal and fatal cardiovascular endpoints such as heart attacks and strokes. Clinical trials have suggested that coenzyme Q10 supplementation can effectively lower blood pressure (BP). |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 2 | 3% |
Canada | 1 | 1% |
Unknown | 64 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 15 | 22% |
Researcher | 12 | 18% |
Student > Master | 11 | 16% |
Student > Postgraduate | 8 | 12% |
Student > Ph. D. Student | 5 | 7% |
Other | 10 | 15% |
Unknown | 6 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 35 | 52% |
Nursing and Health Professions | 10 | 15% |
Agricultural and Biological Sciences | 8 | 12% |
Biochemistry, Genetics and Molecular Biology | 4 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 1 | 1% |
Unknown | 7 | 10% |